H M Engleman
Overview
Explore the profile of H M Engleman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu C, Vennelle M, Li H, Engleman H, Dennis M, Douglas N
J Neurol Neurosurg Psychiatry
. 2006 Jun;
77(10):1143-9.
PMID: 16772358
Background: Sleep-disordered breathing (SDB) is common after stroke, but it is unclear whether it should be treated. Objective: To conduct a randomised controlled trial of continuous positive airway pressure (CPAP)...
2.
3.
Wild M, Engleman H, Douglas N, Espie C
Eur Respir J
. 2004 Sep;
24(3):461-5.
PMID: 15358707
The present study objective was to establish whether pretreatment social cognitive variables may contribute to the explanation of variance in adherence to continuous positive airway pressure (CPAP) treatment for patients...
4.
Engleman H, Douglas N
Thorax
. 2004 Jun;
59(7):618-22.
PMID: 15223874
Sleepiness, cognitive performance, and quality of life are overlapping aspects of daytime function that may be affected in patients with obstructive sleep apnoea/hypopnoea syndrome. The evidence is compatible with hypotheses...
5.
McFadyen T, Espie C, McArdle N, Douglas N, Engleman H
Eur Respir J
. 2002 Feb;
18(6):996-1002.
PMID: 11829108
The aim of the study was to investigate psychosocial function before and after continuous positive airway pressure (CPAP) therapy, and establish the determinants and consequences of objective CPAP use. In...
6.
McArdle N, Kingshott R, Engleman H, Mackay T, Douglas N
Thorax
. 2001 Jun;
56(7):513-8.
PMID: 11413348
Background: The sleep apnoea/hypopnoea syndrome (SAHS) causes snoring, apnoeas, and restlessness during sleep which partners frequently complain about. A study was undertaken to determine the impact on partners of SAHS...
7.
Kingshott R, Vennelle M, COLEMAN E, Engleman H, Mackay T, Douglas N
Am J Respir Crit Care Med
. 2001 Apr;
163(4):918-23.
PMID: 11282766
Some patients with the sleep apnea/hypopnea syndrome (SAHS) remain subjectively and objectively sleepy despite using effective continuous positive airway pressure (CPAP) therapy. The aim of this single center study was...
8.
Douglas N, Engleman H
Sleep
. 2000 Jul;
23 Suppl 4:S147-9.
PMID: 10893090
There have been relatively few robust studies of the effects of CPAP therapy on vigilance and daytime function. This article will use all known published and unpublished randomized clinical trials...
9.
Engleman H, Kingshott R, Martin S, Douglas N
Sleep
. 2000 Jul;
23 Suppl 4:S102-8.
PMID: 10893080
The magnitude, determinants and reversibility of cognitive deficits associated with the sleep apnea/hypopnea syndrome (SAHS) are of clinical and research interest. A quantitative overview of impairment effect sizes (ESs) from...
10.
Kingshott R, Vennelle M, Hoy C, Engleman H, Deary I, Douglas N
Am J Respir Crit Care Med
. 2000 Mar;
161(3 Pt 1):866-71.
PMID: 10712335
Continuous positive airway pressure (CPAP) therapy improves daytime function in the sleep apnea/ hypopnea syndrome (SAHS) but it is unclear which patients benefit and what factors predict this improvement. To...